Working… Menu
Trial record 1 of 1 for:    Falchi
Previous Study | Return to List | Next Study

Durvalumab in Different Combinations With Pralatrexate, Romidepsin and Oral 5-Azacitidine for Lymphoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03161223
Recruitment Status : Recruiting
First Posted : May 19, 2017
Last Update Posted : May 15, 2019
University of Bologna
Samsung Medical Center
Information provided by (Responsible Party):
Owen A, O'Connor, M.D., Ph.D., Columbia University

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : February 2020
Estimated Study Completion Date : February 2021